Amy Kutschke

771 total citations
13 papers, 463 citations indexed

About

Amy Kutschke is a scholar working on Molecular Biology, Molecular Medicine and Organic Chemistry. According to data from OpenAlex, Amy Kutschke has authored 13 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Molecular Medicine and 5 papers in Organic Chemistry. Recurrent topics in Amy Kutschke's work include Cancer therapeutics and mechanisms (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Amy Kutschke is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Amy Kutschke collaborates with scholars based in United States, Sweden and China. Amy Kutschke's co-authors include Boudewijn L. M. de Jonge, Richard A. Alm, John P. Mueller, Linda G. Otterson, Sushmita D. Lahiri, Gregory S. Basarab, Michael D. Huband, Robert E. McLaughlin, Vincent Galullo and Günther Kern and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Amy Kutschke

13 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Kutschke United States 10 197 150 112 92 68 13 463
Steve Mullin United States 6 180 0.9× 117 0.8× 58 0.5× 20 0.2× 63 0.9× 7 283
Povilas Kavaliauskas Lithuania 11 68 0.3× 52 0.3× 107 1.0× 20 0.2× 38 0.6× 44 345
Ryuta Kishii United States 13 267 1.4× 236 1.6× 132 1.2× 44 0.5× 224 3.3× 17 611
Haroon Mohammad United States 16 279 1.4× 65 0.4× 263 2.3× 99 1.1× 54 0.8× 26 710
S. Ken Tanaka United States 9 98 0.5× 62 0.4× 42 0.4× 31 0.3× 47 0.7× 11 359
Carolyn Shoen United States 16 335 1.7× 125 0.8× 164 1.5× 65 0.7× 53 0.8× 31 829
Katsuhiko Mitachi United States 14 262 1.3× 49 0.3× 211 1.9× 19 0.2× 71 1.0× 33 531
Shajila Siricilla United States 11 229 1.2× 50 0.3× 119 1.1× 14 0.2× 54 0.8× 17 382
Linda G. Otterson United States 6 120 0.6× 70 0.5× 78 0.7× 83 0.9× 49 0.7× 6 277
Timothy J. Miles United Kingdom 12 346 1.8× 142 0.9× 299 2.7× 17 0.2× 124 1.8× 24 616

Countries citing papers authored by Amy Kutschke

Since Specialization
Citations

This map shows the geographic impact of Amy Kutschke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Kutschke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Kutschke more than expected).

Fields of papers citing papers by Amy Kutschke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Kutschke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Kutschke. The network helps show where Amy Kutschke may publish in the future.

Co-authorship network of co-authors of Amy Kutschke

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Kutschke. A scholar is included among the top collaborators of Amy Kutschke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Kutschke. Amy Kutschke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Basarab, Gregory S., P. Doig, Charles J. Eyermann, et al.. (2020). Antibacterial Spiropyrimidinetriones with N-Linked Azole Substituents on a Benzisoxazole Scaffold Targeting DNA Gyrase. Journal of Medicinal Chemistry. 63(20). 11882–11901. 15 indexed citations
3.
Lahiri, Sushmita D., et al.. (2015). Insights into the Mechanism of Inhibition of Novel Bacterial Topoisomerase Inhibitors from Characterization of Resistant Mutants of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 59(9). 5278–5287. 29 indexed citations
4.
Murphy-Benenato, Kerry E., Lakshmaiah Gingipalli, P. Ann Boriack‐Sjodin, et al.. (2015). Negishi cross-coupling enabled synthesis of novel NAD+-dependent DNA ligase inhibitors and SAR development. Bioorganic & Medicinal Chemistry Letters. 25(22). 5172–5177. 9 indexed citations
5.
Basarab, Gregory S., P. Doig, Vincent Galullo, et al.. (2015). Discovery of Novel DNA Gyrase Inhibiting Spiropyrimidinetriones: Benzisoxazole Fusion with N-Linked Oxazolidinone Substituents Leading to a Clinical Candidate (ETX0914). Journal of Medicinal Chemistry. 58(15). 6264–6282. 56 indexed citations
6.
Kim, Aryun, Amy Kutschke, David E. Ehmann, et al.. (2015). Pharmacodynamic Profiling of a Siderophore-Conjugated Monocarbam in Pseudomonas aeruginosa: Assessing the Risk for Resistance and Attenuated Efficacy. Antimicrobial Agents and Chemotherapy. 59(12). 7743–7752. 66 indexed citations
7.
Huband, Michael D., Patricia A. Bradford, Linda G. Otterson, et al.. (2014). In Vitro Antibacterial Activity of AZD0914, a New Spiropyrimidinetrione DNA Gyrase/Topoisomerase Inhibitor with Potent Activity against Gram-Positive, Fastidious Gram-Negative, and Atypical Bacteria. Antimicrobial Agents and Chemotherapy. 59(1). 467–474. 60 indexed citations
8.
Alm, Richard A., Sushmita D. Lahiri, Amy Kutschke, et al.. (2014). Characterization of the Novel DNA Gyrase Inhibitor AZD0914: Low Resistance Potential and Lack of Cross-Resistance in Neisseria gonorrhoeae. Antimicrobial Agents and Chemotherapy. 59(3). 1478–1486. 72 indexed citations
9.
Basarab, Gregory S., Patrick Brassil, P. Doig, et al.. (2014). Novel DNA Gyrase Inhibiting Spiropyrimidinetriones with a Benzisoxazole Scaffold: SAR and in Vivo Characterization. Journal of Medicinal Chemistry. 57(21). 9078–9095. 44 indexed citations
10.
Hale, Michael, Pamela Hill, Sushmita D. Lahiri, et al.. (2013). Exploring the UDP pocket of LpxC through amino acid analogs. Bioorganic & Medicinal Chemistry Letters. 23(8). 2362–2367. 20 indexed citations
11.
Jonge, Boudewijn L. M. de, Amy Kutschke, Maria Uria-Nickelsen, Heather D. Kamp, & Scott D. Mills. (2009). Pyrazolopyrimidinediones Are Selective Agents for Helicobacter pylori That Suppress Growth through Inhibition of Glutamate Racemase (MurI). Antimicrobial Agents and Chemotherapy. 53(8). 3331–3336. 30 indexed citations
12.
Newman, Joseph, Michael Rooney, Boudewijn de Jonge, Amy Kutschke, & C. Cederberg. (2007). P796 In vitro and in vivo pharmacokinetics of 2-methylamino-benzodiazepines to treat Helicobacter pylori infections. International Journal of Antimicrobial Agents. 29. S200–S200. 1 indexed citations
13.
Kutschke, Amy & Boudewijn L. M. de Jonge. (2005). Compound Efflux in Helicobacter pylori. Antimicrobial Agents and Chemotherapy. 49(7). 3009–3010. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026